WT1 vaccination in AML and MDS: A pilot trial with synthetic analog peptides
about
Wilms tumor 1 mutations in the pathogenesis of acute myeloid leukemiaA new peptide vaccine OCV-501: in vitro pharmacology and phase 1 study in patients with acute myeloid leukemiaWilms tumor 1 peptide vaccination after hematopoietic stem cell transplant in leukemia patients.Challenges in vaccine therapy in hematological malignancies and strategies to overcome them.Targeting of the WT191-138 fragment to human dendritic cells improves leukemia-specific T-cell responses providing an alternative approach to WT1-based vaccination.Molecular cloning of canine Wilms' tumor 1 for immunohistochemical analysis in canine tissues.Development of cellular and humoral response against WT1 protein vaccination in mice.Phase 1/2 study of the WT1 peptide cancer vaccine WT4869 in patients with myelodysplastic syndrome.Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia.Individualized vaccination of AML patients in remission is associated with induction of antileukemia immunity and prolonged remissions.
P2860
Q26744111-5C6E8A53-307D-4C77-968C-0B945BFA10EAQ33849643-A34E3059-E644-450D-B3F4-F9CCDFCF9C81Q37574653-37C54927-F68F-4D11-8E4C-76E53AB1E559Q38843235-3120EA8A-3842-471F-86E8-A31CEE6D9A59Q40452198-B8290AE4-8761-49D1-A56B-20799036245BQ41435894-DADB75AA-D8C4-40E7-84C4-7F2BE307F51FQ42386145-85604BC1-445F-4FC6-B469-586F678C381EQ42693220-BCE83547-94FA-426F-B38D-86CD307030B3Q43297784-7AF4B110-7C0E-4287-9DF8-BAAD39F85168Q49972906-93C6536B-F2D5-4568-89E6-E2437AB00769
P2860
WT1 vaccination in AML and MDS: A pilot trial with synthetic analog peptides
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
WT1 vaccination in AML and MDS: A pilot trial with synthetic analog peptides
@ast
WT1 vaccination in AML and MDS: A pilot trial with synthetic analog peptides
@en
type
label
WT1 vaccination in AML and MDS: A pilot trial with synthetic analog peptides
@ast
WT1 vaccination in AML and MDS: A pilot trial with synthetic analog peptides
@en
prefLabel
WT1 vaccination in AML and MDS: A pilot trial with synthetic analog peptides
@ast
WT1 vaccination in AML and MDS: A pilot trial with synthetic analog peptides
@en
P2093
P2860
P356
P1476
WT1 vaccination in AML and MDS: A pilot trial with synthetic analog peptides
@en
P2093
Jason Brayer
Javier Pinilla-Ibarz
Jeffrey E Lancet
Lodovico Balducci
Rami Komrokji
P2860
P304
P356
10.1002/AJH.24014
P577
2015-05-03T00:00:00Z